Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-p...

Basic Information

ID: ALA4009438

Type: ADME

Description: Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 1 hr by UPLC-MS/MS analysis

Format: BAO_0000219

Organism: Homo sapiens

Target: Adenosine kinase(ALA3589)

Document: ALA4007430

Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 1 hr by UPLC-MS/MS analysis: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4009438

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
455.39	1.10	1.10

Parent Molecular Weight

ALogP

Polar Surface Area

455.39

1.10

Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-p...

Basic Information

Activity Charts

Compound Summary